Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological effects of acute and accumulated salbutamol in relation to doping analysis
2016-002819-18Phase 2Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of salbutamol, sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Urine concentrations of salbutamol. Started Sep 2016; status: completed.
02
Drugs
salbutamol
Beyond the preview
Go deeper on 2016-002819-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002819-18.